Skip to main content
Erschienen in: Virchows Archiv 4/2022

05.02.2022 | Original Article

Distinctive patterns of marrow involvement by classic Hodgkin lymphoma are clues for diagnosis and subtyping

verfasst von: Hsin-Ni Li, Ren Ching Wang, Chuan-Han Chen, Jun-Peng Chen, Sheau-Fang Yang, Shang-Wen Chen, Shih-Sung Chuang

Erschienen in: Virchows Archiv | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Classic Hodgkin lymphoma (CHL) is a lymphoid neoplasm deriving from B cells in a rich inflammatory background. There are four histological subtypes with different epidemiological features. Bone marrow involvement by CHL is infrequent, and subtyping CHL from the bone marrow is not suggested as there might be discordant histopathology between the primary tumors and bone marrow specimens. In this study, we aimed to identify the histopathological features of bone marrow involved by CHL and tried to correlate these features with their subtypes. Among the 23 recruited cases, the frequencies of mixed cellularity (MC; 48%, 11/23) and nodular sclerosis (NS; 44%, 10/23) were similar. There were two patterns of marrow involvement: pattern A (fibrous), space-occupying lesions with alternating hypo- and hypercellular areas against a fibrotic background with dilated sinusoids and pattern B (histiocyte-rich), ill-defined granuloma-like lesions in which histiocytes merged with normal hematopoietic and inflammatory cells. Pattern A was more frequent in patients with CHL-NS than CHL-MC (100% vs. 18.2%; p < 0.001). Diagnostic Hodgkin cells and Reed-Sternberg (HRS) cells were identified in all cases, while HRS variant lacunar cells were occasionally discovered, particularly in the CHL-NS subtype (NS 100% vs. MC 9%; p < 0.001). The frequency of EBV association was higher in MC (64%) than that in NS (36%) subtype, but not statistically significant. Of the two patterns of marrow involvement, pattern A was more commonly associated with the NS subtype and less frequently associated with EBV. Recognizing the patterns of marrow involvement is important for diagnosis and may contribute to the subtyping of CHL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chuang SS, Chen SW, Chang ST, Kuo YT (2017) Lymphoma in Taiwan: review of 1347 neoplasms from a single institution according to the 2016 Revision of the World Health Organization Classification. J Formos Med Assoc 116(8):620–625CrossRefPubMed Chuang SS, Chen SW, Chang ST, Kuo YT (2017) Lymphoma in Taiwan: review of 1347 neoplasms from a single institution according to the 2016 Revision of the World Health Organization Classification. J Formos Med Assoc 116(8):620–625CrossRefPubMed
3.
Zurück zum Zitat Wang HW, Balakrishna JP, Pittaluga S, Jaffe ES (2019) Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol 184(1):45–59CrossRefPubMed Wang HW, Balakrishna JP, Pittaluga S, Jaffe ES (2019) Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol 184(1):45–59CrossRefPubMed
4.
Zurück zum Zitat Piris MA, Medeiros LJ, Chang KC (2020) Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis. Pathology 52(1):154–165CrossRefPubMed Piris MA, Medeiros LJ, Chang KC (2020) Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis. Pathology 52(1):154–165CrossRefPubMed
5.
Zurück zum Zitat Cartwright RA, Watkins G (2004) Epidemiology of Hodgkin’s disease: a review. Hematol Oncol 22(1):11–26CrossRefPubMed Cartwright RA, Watkins G (2004) Epidemiology of Hodgkin’s disease: a review. Hematol Oncol 22(1):11–26CrossRefPubMed
6.
Zurück zum Zitat Eberle FC, Mani H, Jaffe ES (2009) Histopathology of Hodgkin’s lymphoma. Cancer J 15(2):129–137CrossRefPubMed Eberle FC, Mani H, Jaffe ES (2009) Histopathology of Hodgkin’s lymphoma. Cancer J 15(2):129–137CrossRefPubMed
7.
Zurück zum Zitat Pileri SA, Ascani S, Leoncini L, Sabattini E, Zinzani PL, Piccaluga PP, Pileri A Jr, Giunti M, Falini B, Bolis GB et al (2002) Hodgkin’s lymphoma: the pathologist’s viewpoint. J Clin Pathol 55(3):162–176CrossRefPubMedPubMedCentral Pileri SA, Ascani S, Leoncini L, Sabattini E, Zinzani PL, Piccaluga PP, Pileri A Jr, Giunti M, Falini B, Bolis GB et al (2002) Hodgkin’s lymphoma: the pathologist’s viewpoint. J Clin Pathol 55(3):162–176CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (2017) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, vol. 2, Revised 4th edn: IARC Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (2017) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, vol. 2, Revised 4th edn: IARC
9.
Zurück zum Zitat Laurent C, Arber DA, Johnston P, Fend F, Zamo A, Attygalle AD (2020) Diagnosis of classic Hodgkin lymphoma on bone marrow biopsy. Histopathology 76(7):934–941CrossRefPubMed Laurent C, Arber DA, Johnston P, Fend F, Zamo A, Attygalle AD (2020) Diagnosis of classic Hodgkin lymphoma on bone marrow biopsy. Histopathology 76(7):934–941CrossRefPubMed
10.
Zurück zum Zitat Franco V, Tripodo C, Rizzo A, Stella M, Florena AM (2004) Bone marrow biopsy in Hodgkin’s lymphoma. Eur J Haematol 73(3):149–155CrossRefPubMed Franco V, Tripodo C, Rizzo A, Stella M, Florena AM (2004) Bone marrow biopsy in Hodgkin’s lymphoma. Eur J Haematol 73(3):149–155CrossRefPubMed
11.
Zurück zum Zitat Munker R, Hasenclever D, Brosteanu O, Hiller E, Diehl V (1995) Bone marrow involvement in Hodgkin’s disease: an analysis of 135 consecutive cases. German Hodgkin’s Lymphoma Study Group. J Clin Oncol 13(2):403–409CrossRefPubMed Munker R, Hasenclever D, Brosteanu O, Hiller E, Diehl V (1995) Bone marrow involvement in Hodgkin’s disease: an analysis of 135 consecutive cases. German Hodgkin’s Lymphoma Study Group. J Clin Oncol 13(2):403–409CrossRefPubMed
12.
Zurück zum Zitat Ponzoni M, Fumagalli L, Rossi G, Freschi M, Re A, Vigano MG, Guidoboni M, Dolcetti R, McKenna RW, Facchetti F (2002) Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol 15(12):1273–1278CrossRefPubMed Ponzoni M, Fumagalli L, Rossi G, Freschi M, Re A, Vigano MG, Guidoboni M, Dolcetti R, McKenna RW, Facchetti F (2002) Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol 15(12):1273–1278CrossRefPubMed
13.
Zurück zum Zitat Lukes RJ (1971) Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin’s disease. Cancer Res 31(11):1755–1767PubMed Lukes RJ (1971) Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin’s disease. Cancer Res 31(11):1755–1767PubMed
14.
Zurück zum Zitat Hsu SM, Yang K, Jaffe ES (1985) Phenotypic expression of Hodgkin’s and Reed-Sternberg cells in Hodgkin’s disease. Am J Pathol 118(2):209–217PubMedPubMedCentral Hsu SM, Yang K, Jaffe ES (1985) Phenotypic expression of Hodgkin’s and Reed-Sternberg cells in Hodgkin’s disease. Am J Pathol 118(2):209–217PubMedPubMedCentral
15.
Zurück zum Zitat Chittal SM, Caveriviere P, Schwarting R, Gerdes J, Al Saati T, Rigal-Huguet F, Stein H, Delsol G (1988) Monoclonal antibodies in the diagnosis of Hodgkin’s disease. The search for a rational panel. Am J Surg Pathol 12(1):9–21CrossRefPubMed Chittal SM, Caveriviere P, Schwarting R, Gerdes J, Al Saati T, Rigal-Huguet F, Stein H, Delsol G (1988) Monoclonal antibodies in the diagnosis of Hodgkin’s disease. The search for a rational panel. Am J Surg Pathol 12(1):9–21CrossRefPubMed
16.
Zurück zum Zitat Chuang SS (2017) Infrequent expression of CD15 by classical Hodgkin’s lymphomas in Taiwan. J Clin Pathol 70(2):183–184CrossRefPubMed Chuang SS (2017) Infrequent expression of CD15 by classical Hodgkin’s lymphomas in Taiwan. J Clin Pathol 70(2):183–184CrossRefPubMed
17.
Zurück zum Zitat Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 339(21):1506–1514CrossRefPubMed Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 339(21):1506–1514CrossRefPubMed
18.
Zurück zum Zitat Gianelli U, Vener C, Bossi A, Cortinovis I, Iurlo A, Fracchiolla NS, Savi F, Moro A, Grifoni F, De Philippis C et al (2012) The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. Mod Pathol 25(9):1193–1202CrossRefPubMed Gianelli U, Vener C, Bossi A, Cortinovis I, Iurlo A, Fracchiolla NS, Savi F, Moro A, Grifoni F, De Philippis C et al (2012) The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. Mod Pathol 25(9):1193–1202CrossRefPubMed
19.
Zurück zum Zitat Wu CY, Wang RC, Chen BJ, Chen WY, Jhuang JY, Chang MC, Wu YH, Nakada N, Karube K, Chuang SS (2020) granuloma with an underlying lymphoma: a diagnostic challenge and a wider histologic spectrum including adult T-cell leukemia/lymphoma. Appl Immunohistochem Mol Morphol 28(4):316–324CrossRefPubMed Wu CY, Wang RC, Chen BJ, Chen WY, Jhuang JY, Chang MC, Wu YH, Nakada N, Karube K, Chuang SS (2020) granuloma with an underlying lymphoma: a diagnostic challenge and a wider histologic spectrum including adult T-cell leukemia/lymphoma. Appl Immunohistochem Mol Morphol 28(4):316–324CrossRefPubMed
20.
Zurück zum Zitat O’Carroll DI, McKenna RW, Brunning RD (1976) Bone marrow manifestations of Hodgkin’s disease. Cancer 38(4):1717–1728CrossRefPubMed O’Carroll DI, McKenna RW, Brunning RD (1976) Bone marrow manifestations of Hodgkin’s disease. Cancer 38(4):1717–1728CrossRefPubMed
21.
Zurück zum Zitat Shi YF, Li XH, Song YQ, Song WW, Lai YM (2015) Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China. Int J Clin Exp Pathol 8(6):7102–7111PubMedPubMedCentral Shi YF, Li XH, Song YQ, Song WW, Lai YM (2015) Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China. Int J Clin Exp Pathol 8(6):7102–7111PubMedPubMedCentral
22.
Zurück zum Zitat Schnitter A, Kohler CW, Reddemann K, Reinke S, Thorns C, Fend F, Federmann B, Möller P, Szczepanowski M, Spang R et al (2019) Therapeutic targets and microenvironment in sequential biopsies of classical Hodgkin lymphoma at diagnosis and relapse. J Hematop 12:11–17CrossRef Schnitter A, Kohler CW, Reddemann K, Reinke S, Thorns C, Fend F, Federmann B, Möller P, Szczepanowski M, Spang R et al (2019) Therapeutic targets and microenvironment in sequential biopsies of classical Hodgkin lymphoma at diagnosis and relapse. J Hematop 12:11–17CrossRef
23.
Zurück zum Zitat Aldinucci D, Borghese C, Casagrande N (2019) formation of the immunosuppressive microenvironment of classic Hodgkin lymphoma and therapeutic approaches to counter It. Int J Mol Sci 20(10):2416CrossRefPubMedCentral Aldinucci D, Borghese C, Casagrande N (2019) formation of the immunosuppressive microenvironment of classic Hodgkin lymphoma and therapeutic approaches to counter It. Int J Mol Sci 20(10):2416CrossRefPubMedCentral
24.
Zurück zum Zitat Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD et al (2010) Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma. N Engl J Med 362(10):875–885CrossRefPubMedPubMedCentral Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD et al (2010) Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma. N Engl J Med 362(10):875–885CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Zaki MA, Wada N, Ikeda J, Shibayama H, Hashimoto K, Yamagami T, Tatsumi Y, Tsukaguchi M, Take H, Tsudo M et al (2011) Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch 459(4):361–366CrossRefPubMed Zaki MA, Wada N, Ikeda J, Shibayama H, Hashimoto K, Yamagami T, Tatsumi Y, Tsukaguchi M, Take H, Tsudo M et al (2011) Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch 459(4):361–366CrossRefPubMed
26.
Zurück zum Zitat Klein JL, Nguyen TT, Bien-Willner GA, Chen L, Foyil KV, Bartlett NL, Duncavage EJ, Hassan A, Frater JL, Kreisel F (2014) CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma. Am J Clin Pathol 141(3):381–387CrossRefPubMed Klein JL, Nguyen TT, Bien-Willner GA, Chen L, Foyil KV, Bartlett NL, Duncavage EJ, Hassan A, Frater JL, Kreisel F (2014) CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma. Am J Clin Pathol 141(3):381–387CrossRefPubMed
27.
Zurück zum Zitat Peng F, Qin Y, Mu S, Li J, Ai L, Hu Y (2020) Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis. J Cancer Res Clin Oncol 146(12):3123–3135CrossRefPubMed Peng F, Qin Y, Mu S, Li J, Ai L, Hu Y (2020) Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis. J Cancer Res Clin Oncol 146(12):3123–3135CrossRefPubMed
28.
Zurück zum Zitat Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Perin V, Todesco M, De Iuliis A, Improta S, Sacco C et al (1997) The role of eosinophils in the pathobiology of Hodgkin’s disease. Ann Oncol 8(Suppl 2):89–96CrossRefPubMed Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Perin V, Todesco M, De Iuliis A, Improta S, Sacco C et al (1997) The role of eosinophils in the pathobiology of Hodgkin’s disease. Ann Oncol 8(Suppl 2):89–96CrossRefPubMed
29.
Zurück zum Zitat Kadin M, Butmarc J, Elovic A, Wong D (1993) Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin’s disease. Am J Pathol 142(1):11–16PubMedPubMedCentral Kadin M, Butmarc J, Elovic A, Wong D (1993) Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin’s disease. Am J Pathol 142(1):11–16PubMedPubMedCentral
30.
Zurück zum Zitat Mohty R, Dulery R, Bazarbachi AH, Savani M, Hamed RA, Bazarbachi A, Mohty M (2021) Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies. Blood Cancer J 11(7):126CrossRefPubMedPubMedCentral Mohty R, Dulery R, Bazarbachi AH, Savani M, Hamed RA, Bazarbachi A, Mohty M (2021) Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies. Blood Cancer J 11(7):126CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Devilard E, Bertucci F, Trempat P, Bouabdallah R, Loriod B, Giaconia A, Brousset P, Granjeaud S, Nguyen C, Birnbaum D et al (2002) Gene expression profiling defines molecular subtypes of classical Hodgkin’s disease. Oncogene 21(19):3095–3102CrossRefPubMed Devilard E, Bertucci F, Trempat P, Bouabdallah R, Loriod B, Giaconia A, Brousset P, Granjeaud S, Nguyen C, Birnbaum D et al (2002) Gene expression profiling defines molecular subtypes of classical Hodgkin’s disease. Oncogene 21(19):3095–3102CrossRefPubMed
32.
Zurück zum Zitat Bienz M, Ramdani S, Knecht H (2020) Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future. Int J Mol Sci 21(18):6623CrossRefPubMedCentral Bienz M, Ramdani S, Knecht H (2020) Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future. Int J Mol Sci 21(18):6623CrossRefPubMedCentral
33.
34.
Zurück zum Zitat Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Littooij AS, Nievelstein RA (2014) Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol 25(5):921–927CrossRefPubMed Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Littooij AS, Nievelstein RA (2014) Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol 25(5):921–927CrossRefPubMed
35.
Zurück zum Zitat Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM (2015) Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? Ann Nucl Med 29(2):132–137CrossRefPubMed Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM (2015) Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? Ann Nucl Med 29(2):132–137CrossRefPubMed
36.
Zurück zum Zitat Puccini B, Nassi L, Minoia C, Volpetti S, Ciancia R, Riccomagno PC, Di Rocco A, Mule A, Toldo C, Sassone MC et al (2017) Role of bone marrow biopsy in staging of patients with classical Hodgkin’s lymphoma undergoing positron emission tomography/computed tomography. Ann Hematol 96(7):1147–1153CrossRefPubMed Puccini B, Nassi L, Minoia C, Volpetti S, Ciancia R, Riccomagno PC, Di Rocco A, Mule A, Toldo C, Sassone MC et al (2017) Role of bone marrow biopsy in staging of patients with classical Hodgkin’s lymphoma undergoing positron emission tomography/computed tomography. Ann Hematol 96(7):1147–1153CrossRefPubMed
37.
Zurück zum Zitat Voltin CA, Goergen H, Baues C, Fuchs M, Mettler J, Kreissl S, Oertl J, Klaeser B, Moccia A, Drzezga A et al (2018) Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18. Ann Oncol 29(9):1926–1931CrossRefPubMed Voltin CA, Goergen H, Baues C, Fuchs M, Mettler J, Kreissl S, Oertl J, Klaeser B, Moccia A, Drzezga A et al (2018) Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18. Ann Oncol 29(9):1926–1931CrossRefPubMed
38.
Zurück zum Zitat Gulley ML, Eagan PA, Quintanilla-Martinez L, Picado AL, Smir BN, Childs C, Dunn CD, Craig FE, Williams JW Jr, Banks PM (1994) Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin’s disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood 83(6):1595–1602CrossRefPubMed Gulley ML, Eagan PA, Quintanilla-Martinez L, Picado AL, Smir BN, Childs C, Dunn CD, Craig FE, Williams JW Jr, Banks PM (1994) Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin’s disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood 83(6):1595–1602CrossRefPubMed
39.
Zurück zum Zitat Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang JS, Madsen M, Rosdahl N, Konradsen HB, Storm HH et al (2003) Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N Engl J Med 349(14):1324–1332CrossRefPubMed Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang JS, Madsen M, Rosdahl N, Konradsen HB, Storm HH et al (2003) Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N Engl J Med 349(14):1324–1332CrossRefPubMed
40.
Zurück zum Zitat Chang KC, Chen PC, Jones D, Su IJ (2008) Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci 99(2):345–349CrossRefPubMed Chang KC, Chen PC, Jones D, Su IJ (2008) Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci 99(2):345–349CrossRefPubMed
Metadaten
Titel
Distinctive patterns of marrow involvement by classic Hodgkin lymphoma are clues for diagnosis and subtyping
verfasst von
Hsin-Ni Li
Ren Ching Wang
Chuan-Han Chen
Jun-Peng Chen
Sheau-Fang Yang
Shang-Wen Chen
Shih-Sung Chuang
Publikationsdatum
05.02.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 4/2022
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-022-03273-z

Weitere Artikel der Ausgabe 4/2022

Virchows Archiv 4/2022 Zur Ausgabe

Neu im Fachgebiet Pathologie